Vitamin D-mediated apoptosis in cancer and obesity

Hormone Molecular Biology and Clinical Investigation

Volumn 20, Issue 2, 2014, Pages 43-49

  Sergeev, Igor N ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

apoptosis; calpains; cancer; caspases; intracellular Ca2+; obesity; vitamin D

Indexed keywords

CALCITRIOL; CALCIUM ION; CALPAIN; CASPASE; SECALCIFEROL; VITAMIN D; VITAMIN D RECEPTOR; COLECALCIFEROL;

ADIPOCYTE; ADIPOSE TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CANCER SIZE; CELL DEATH; HUMAN; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; NUTRITIONAL REQUIREMENT; OBESITY; PHYSIOLOGICAL PROCESS; REGULATORY MECHANISM; VITAMIN D METABOLISM; CALCIUM SIGNALING; DRUG EFFECTS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CALCIUM SIGNALING; CHOLECALCIFEROL; HUMANS; NEOPLASMS; OBESITY;

EID: 84922796263     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2014-0035     Document Type: Article

References (50)

1. Sergeev IN, Rhoten WB, Spirichev VB. Vitamin D and intracellular calcium. Subcell Biochem 1998;30:271-97.
2. 3, a steroid hormone that produces biological effects via genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992;41:231-40.
3. Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L, Bilke DD. Vitamin D: beyond bone. Ann NY Acad Sci 2013;1287:45-58.
4. 3: a link between metabolic disorders and breast cancer. Horm Mol Biol Clin Invest 2013;14:99-106.
5. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med 2010;235:1034-45.
6. 2+ signaling in breast cancer. Anticancer Res 2012;32:299-302.
7. Sergeev IN. Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol 2005;97:145-51.
8. 3-induced apoptosis. J Steroid Biochem Mol Biol 2004; 89-90:419-25.
9. Berridge MJ, Bootman MD, Lipp P. Calcium: a life and death signal. Nature 1988;395:645-8.
10. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003;4: 552-65.
11. Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev 2012;25:130-41.
12. Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann NY Acad Sci 2012;1271: 37-43.
13. Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, Jaattela M. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 2002;277:30738-45.
14. Sergeev IN, Rhoten WB. Regulation of intracellular calcium in breast cancer cells. Endocrine 1998;9:321-7.
15. 3 evokes oscillations of intracellular calcium in a pancreatic β-cell line. Endocrinology 1995;136:2852-61.
16. Bikle DD. The vitamin D receptor: a tumor suppressor in skin. Adv Exp Med Biol 2014;810:282-302.
17. Ordonez Mena JM, Brenner H. Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol 2014;810:17-32.
18. Li M, Chen P, Li J, Chu R, Xie D, Wang H. The impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:2327-36.
19. Narvaez CJ, Matthews D, LaPorta E, Simmons KM, Beaudin S, Welsh J. The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Front Physiol 2014;5:213.
20. 2+-mediated apoptosis in adipocytes via activation of calpain and cas-pase-12. Biochem Biophys Res Commun 2009;384:18-21.
21. Hursting SD, Dunlap SM. Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvi-ronmental) issue. Ann NY Acad Sci 2012;1271:82-7.
22. Institute of Medicine. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011.
23. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
25. Scientific Opinion on the Tolerable Upper Intake Level of vitamin D. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). European Food Safety Authority (EFSA). EFSA J 2012; 10: 2813 (pp.1-45).
26. Spirichev VB, Sergeev IN. Vitamin D: experimental research and its practical application. World Rev Nutr Diet 1988;56:173-216.
27. Lamberg-Allardt C, Brustad M, Meyer HE, Steingrimsdottir L. Vitamin D-a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations. Food Nutr Res 2013;57:22671.
28. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2014;810: 500-25.
29. 3 in intact animals. Endocrinology 1999;140:2224-31.
30. Sergeev IN, Arkhapchev YP, Spirichev VB. Ascorbic acid effects on vitamin D metabolism and binding in guinea pigs. J Nutr 1990;120:1185-90.
31. 3 and two analogs. Cancer Res 1993;53:3935-42.
32. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 1991;129:1876-84.
33. Sergeev IN. Vitamin D/calcium-mediated apoptosis in cancer cells and adipocytes. FASEB J 2010;24:917.16.
34. Nemere I, Hintze K. Novel hormone "receptors". J Cell Biochem 2008;103:401-7.
35. 2+ signaling. FASEB J 2012;26:386.2.
36. 2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Bio-phys Res Commun 2004;321:462-7.
37. 3 and calcium signaling. In: Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects. Riverside: University of California, 2000:715-8.
38. 2+ and apoptosis in breast cancer cells. In: Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside: University of California, 1997:473-4.
39. 3 triggers calcium-mediated apoptosis in breast cancer cells. In: Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects. Riverside: University of California, 2000: 399-402.
40. Sergeev IN, Rhoten WB. Video imaging of calcium and pH in breast cancer cells. Mol Biol Cell 1995;6:351.
41. Sergeev IN, Norman AW. Calcium as a mediator of apoptosis in bovine oocytes and preimplantation embryos. Endocrine 2003;22:169-75.
42. Carafoli E, Santella L, Branca D, Brini M. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 2001;36:107-260.
43. McConkey DL, Orrenius S. The role of calcium in regulation of apoptosis. Biochem Biophys Res Commun 1997;239:357-66.
44. Carafoli E, Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commun 1998;247:193-203.
45. Sergeev IN, Rhoten WB, Carney MD. Calbindins decreased after space flight. Endocrine 1996;5:335-40, cover illustration.
46. 2+ in butyrate-treated rat insulinoma cells. Endocrine 1994;2:989-95.
47. 2+-mediated apoptosis in breast cancer cells. Life Sci 2006;80:245-53.
48. Sergeev IN, Ho C-T, Lee S, Colby J, Dushenkov S. Apoptosis-inducing activity of hydroxylated polymethoxyflavones and polymethoxyflavones from orange peel in human breast cancer cells. Mol Nutr Food Res 2007;51:1478-84.
49. 2+-dependent apoptotic targets in adipo-cytes. J Agric Food Chem 2009;57:5771-6.
50. Sergeev IN, Song Q. High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apop-tosis. Mol Nutr Food Res 2014;58:1342-8.